Program
encaleret
Its studies are mostly in Hypocalcemia · Hypoparathyroidism, led by BridgeBio.
Furthest: phase 3, since Dec 12, 20224 company-led studies, 3 open or runningNext primary completion: Jan 2028 (phase 3)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| BridgeBio | 43 open or running | phase 3since Dec 12, 2022 | Sep 16, 2020 | Jan 2028phase 3 · NCT07805356 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 16, 2020First study: phase 2 study in Hypercalciuric Hypocalcemia, FamilialFirst studyNCT04581629 · 13 enrolled · United States
- Dec 12, 2022Phase 3 study in Hypercalciuric Hypocalcemia, FamilialNCT05680818 · 67 enrolled · United States, Australia, Canada and more
- Jul 14, 2025Phase 3 study in Autosomal Dominant Hypocalcemia Type 1 (ADH1)NCT07080385 · 28 planned · United States, United Kingdom
- Sep 1, 2026Phase 3 study in HypoparathyroidismNCT07805356 · 160 planned · United States, Canada, Japan
Ahead
- Jan 2028Primary completion: phase 3 study in HypoparathyroidismNCT07805356
- Dec 2028Primary completion: phase 3 study in Autosomal Dominant Hypocalcemia Type 1 (ADH1)NCT07080385
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07805356Hypoparathyroidism · United States, Canada, Japan | 3 | Recruiting | Jan 2028 | 160 |
| NCT07080385Autosomal Dominant Hypocalcemia Type 1 (ADH1) · United States, United Kingdom | 3 | Recruiting | Dec 2028 | 28 |
| NCT05680818Hypercalciuric Hypocalcemia, Familial · United States, Australia, Canada and more | 3 | Active, not recruiting | Aug 22, 2025 | 67 |
| NCT04581629Hypercalciuric Hypocalcemia, Familial · United States | 2 | Completed | Sep 7, 2023 | 13 |
How it is read
Names in the registry
- “Encaleret”, 4 entries
Conditions, from the studies’ own filings
- Hypocalcemia, 2 studies
- Hypoparathyroidism, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.